Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 124,998 shares at $15.59 ($1.9M) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Scheduled sale ($1.9M) by CEO and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |